SDF-1/CXCR4轴通过NF-κb信号通路调控炎症反应减轻动脉粥样硬化的形成

周明, 汪家文, 路艳林, 彭进, 丁九阳, 乐翠云, 李芳琴, 王杰, 刘玉波, 夏冰

PDF(2825 KB)
PDF(2825 KB)
重庆医科大学学报 ›› 2025, Vol. 50 ›› Issue (02) : 237-243. DOI: 10.13406/j.cnki.cyxb..003655
基础研究

SDF-1/CXCR4轴通过NF-κb信号通路调控炎症反应减轻动脉粥样硬化的形成

作者信息 +

SDF-1/CXCR4 axis regulates inflammatory responses to attenuate atherosclerosis via the NF-κb signaling pathway

Author information +
History +

摘要

目的 确定基质细胞衍生因子-1/趋化因子受体4(stromal cell-derived factor-1/C-X-C chemokine receptor 4,SDF-1/CXCR4)信号轴如何在动脉粥样硬化中发挥作用,并探讨其相关的分子机制。 方法 将40只载脂蛋白E-/-小鼠分为5组:对照组(control group,CON)、高脂饲料组(high-fat diet,HFD)、空载病毒组(adeno-associated virus 9 enhanced green fluorescent protein,AAV9-eGFP)、病毒敲减组(adeno-associated virus 9-CXCR4-small interfering RNA,AAV9-CXCR4-siRNA)和吡咯烷二硫代氨基甲酸酯(pyrrolidine dithiocarbamate,PDTC)组。CON组普通饲料喂养,其余4 组高脂饲料喂养16周。PDTC组从第五周开始腹腔注射60 mg/kg PDTC,2次/周。12周时,AAV9-CXCR4-siRNA组和AAV9-eGFP组分别接受尾静脉注射rAAV9-CXCR4-RNAi和阴性对照病毒,HFD组注射等量生理盐水。使用共聚焦荧光显微镜测定增强型绿色荧光蛋白(enhanced green fluorescent protein,eGFP)的表达,采用苏木精-伊红染色(hematoxylin-eosin,HE)染色法显示动脉粥样硬化斑块的面积,免疫组织化学(immunohistochemistry,IHC)染色和免疫印迹法(Western blot,WB)检测CXCR4、核因子-κB p65(nuclear factor kappaB p65,NF-κB p65)、磷酸化核因子-κB p65(nuclear factor kappaB p-p65,NF-κB p-p65)、白细胞介素-1β(interleukin-1β,IL-1β)和肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)。 结果 HE染色显示,与CON组相比,各组均出现动脉粥样硬化斑块,AAV9-CXCR4-siRNA组的斑块小于AAV9-eGFP组。与HFD组相比,PDTC组的斑块更小。此外,与HFD组相比,PDTC组的血清中SDF-1、IL-1β和TNF-α水平较低;与AAV9-eGFP组相比,PDTC组的SDF-1、IL-1β和TNF-α血清水平更低。IHC结果显示,与CON组相比,CXCR4和SDF-1在HFD组和AAV9-eGFP组中高表达。然而,AAV9-CXCR4-siRNA组与AAV9-eGFP组相比,斑块区域的CXCR4(F=9.621,P=0.000)和SDF-1(F=20.102,P=0.000)表达减少。此外,WB实验表明,与HFD组相比,PDTC 组的 SDF-1(F=54.093,P=0.000)和CXCR4(F=28.485,P=0.000)表达降低。与AAV9-eGFP组相比,AAV9-CXCR4-siRNA组的SDF-1和CXCR4表达量较低(F=9.621,P=0.000;F=20.102,P=0.000)。Pearson相关分析表明,CXCR4与NF-κb p65(r=0.762,P=0.000)、NF-κb p-p65(r=0.795,P=0.000)、白细胞介素-1(interleukin-1,IL-1)(r=0.786,P=0.000)、TNF-α(r=0.844,P=0.000)和SDF-1(r=0.815,P=0.000)蛋白水平呈正相关。 结论 抑制SDF-1/CXCR4轴可通过NF-κb信号通路降低炎症反应,从而减轻动脉粥样硬化的发生发展。

Abstract

Objective To determine the role of stromal cell-derived factor-1/C-X-C chemokine receptor 4(SDF-1/CXCR4) signaling axis in atherosclerosis and to investigate its associated molecular mechanisms. Methods Forty ApoE-/- mice were divided into five groups:control(CON) group,high-fat diet(HFD) group,empty virus(adeno-associated virus 9 enhanced green fluorescent protein,AAV9-eGFP) group,virus knockdown(adeno-associated virus 9-CXCR4-small interfering RNA,AAV9-CXCR4-siRNA) group,and pyrrolidine dithiocarbamate(PDTC) group. The CON group was fed normal chow and the remaining four groups were fed high-fat chow for 16 weeks. The PDTC group received intraperitoneal injections of 60 mg/kg PDTC twice/week starting from the fifth week. At 12 weeks,the AAV9-CXCR4-siRNA group and the AAV9-eGFP group received tail-vein injection of rAAV9-CXCR4-RNAi and negative control viruses,respectively,while the HFD group was injected with an equal amount of physiologic saline. The expression of enhanced green fluorescent protein(eGFP) was determined using confocal fluorescence microscopy. The area of atherosclerotic plaques was visualized by hematoxylin and eosin staining. Immunohistochemical staining and Western blot were used to detect the expression of CXCR4,nuclear factor kappa B p65 (NF-κB p65),phosphorylated nuclear factor-κB p65(NF-κB p-p65),interleukin-1β(IL-1β),and tumor necrosis factor-α(TNF-α). Results Hematoxylin and eosin staining showed that atherosclerotic plaques were clearly present in all groups except the CON group,and plaques in the AAV9-CXCR4-siRNA group were significantly smaller than those in the AAV9-eGFP group. Plaques were significantly smaller in the PDTC group compared with the HFD group. In addition,the serum levels of SDF-1,IL-1β,and TNF-α were lower in the PDTC group compared with the HFD group. The serum levels of SDF-1,IL-1β,and TNF-α were lower in the PDTC group compared with the AAV9-eGFP group. Immunohistochemical staining showed that the expression levels of CXCR4 and SDF-1 were higher in the HFD and AAV9-eGFP groups than in the CON group. However,the expression levels of CXCR4(F=9.621,P=0.000) and SDF-1(F=20.102,P=0.000) were significantly reduced in the plaque region in the AAV9-CXCR4-siRNA group compared with the AAV9-eGFP group. In addition,Western blot showed that the expression levels of SDF-1(F=54.093,P=0.000) and CXCR4(F=28.485,P=0.000) were significantly reduced in the PDTC group compared with the HFD group. SDF-1 and CXCR4 expression levels were significantly lower in the AAV9-CXCR4-siRNA group compared with the AAV9-eGFP group(F=9.621,P=0.000;F=20.102,P=0.000). Pearson correlation analysis showed that CXCR4 was positively correlated with the protein levels of NF-κb p65(r=0.762,P=0.000),NF-κb p-p65(r=0.795,P=0.000),IL-1(r=0.786,P=0.000),TNF-α(r=0.844,P=0.000),and SDF-1(r=0.815,P=0.000). Conclusion Inhibition of the SDF-1/CXCR4 axis reduces the inflammatory response through the NF-κb signaling pathway,thereby attenuating the development and progression of atherosclerosis.

关键词

趋化因子配体12/趋化因子受体4信号轴 / 动脉粥样硬化 / 核因子-κB信号通路 / 炎症反应

Key words

C-X-C motif chemokine ligand 12/C-X-C chemokine receptor 4 axis / atherosclerosis / NF-κb signaling pathway / inflammatory response

中图分类号

R543.5 / R363.2

引用本文

导出引用
周明 , 汪家文 , 路艳林 , . SDF-1/CXCR4轴通过NF-κb信号通路调控炎症反应减轻动脉粥样硬化的形成. 重庆医科大学学报. 2025, 50(02): 237-243 https://doi.org/10.13406/j.cnki.cyxb..003655
Zhou Ming, Wang Jiawen, Lu Yanlin, et al. SDF-1/CXCR4 axis regulates inflammatory responses to attenuate atherosclerosis via the NF-κb signaling pathway[J]. Journal of Chongqing Medical University. 2025, 50(02): 237-243 https://doi.org/10.13406/j.cnki.cyxb..003655

参考文献

1
Bergström G Persson M Adiels M,et al. Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population[J]. Circulation. 2021144(12):916-929.
2
Roth GA Mensah GA Johnson CO,et al. Global burden of cardiovascular diseases and risk factors,1990-2019:update from the GBD 2019 study[J]. J Am Coll Cardiol202076(25):2982-3021.
3
Little WC Constantinescu M Applegate RJ,et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?[J]. Circulation198878(5 Pt 1):1157-1166.
4
Ambrose JA Tannenbaum MA Alexopoulos D,et al. Angiographic progression of coronary artery disease and the development of myocardial infarction[J]. J Am Coll Cardiol198812(1):56-62.
5
Wu BL Chien EY Mol CD,et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists[J]. Science2010330(6007):1066-1071.
6
Baba O Huang LH Elvington A,et al. CXCR4-binding positron emission tomography tracers link monocyte recruitment and endothelial injury in murine atherosclerosis[J]. Arterioscler Thromb Vasc Biol202141(2):822-836.
7
Li LX Du ZL Rong B,et al. Foam cells promote atherosclerosis progression by releasing CXCL12[J]. Biosci Rep202040(1):BSR2019 3267.
8
Döring Y van der Vorst EPC Duchene J,et al. CXCL12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease[J]. Circulation2019139(10):1338-1340.
9
Chen JQ Chemaly E Liang LF,et al. Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury[J]. Am J Pathol2010176(4):1705-1715.
10
Hou JQ Wang C Ma D,et al. The cardioprotective and anxiolytic effects of Chaihujialonggumuli Granule on rats with anxiety after acute myocardial infarction is partly mediated by suppression of CXCR4/NF-κB/GSDMD pathway[J]. Biomedecine Pharmacother2021133:111015.
11
Zhai JX Zhang ZX Feng YJ,et al. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice[J]. Mol Biol Rep201239(6):6763-6771.
12
van Kuijk K Demandt JAF Perales-Patón J,et al. Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling[J]. Cardiovasc Res2022118(5):1232-1246.
13
Gavriel Y Rabinovich-Nikitin I Ezra A,et al. Subcutaneous administration of AMD3100 into mice models of Alzheimer’s disease ameliorated cognitive impairment,reduced neuroinflammation,and improved pathophysiological markers[J]. J Alzheimers Dis202078(2):653-671.
14
Liang DS Huang AR Lin MM,et al. Pyrrolidine dithiocarbamate and dexamethasone are novel treatments of Acute Exogenous Lipoid Pneumonia[J]. Cytokine2020133:155122.
15
Song ZY Wang F Cui SX,et al. Knockdown of CXCR4 inhibits CXCL12-induced angiogenesis in HUVECs through downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-catenin pathways[J]. Cancer Invest201836(1):10-18.
16
Ridker PM Everett BM Thuren T,et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med2017377(12):1119-1131.
17
Gao JH He LH Yu XH,et al. CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway[J]. J Lipid Res201960(12):2020-2033.
18
Gencer S Döring Y Jansen Y,et al. Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium[J]. Basic Res Cardiol2022117(1):30.
19
Gao JH Yu XH Tang CK. CXC chemokine ligand 12 (CXCL12) in atherosclerosis:an underlying therapeutic target[J]. Clin Chim Acta2019495:538-544.
20
Liu T Zhang LY Joo D,et al. NF-κB signaling in inflammation[J]. Signal Transduct Target Ther20172:17023.
21
Li YQ Wang JY Qian ZQ,et al. Osthole inhibits intimal hyperplasia by regulating the NF-κB and TGF-β1/Smad2 signalling pathways in the rat carotid artery after balloon injury[J]. Eur J Pharmacol2017811:232-239.
22
Yao JT Zhao XZ Tan FC,et al. Early modulation of macrophage ROS-PPARγ-NF-κB signalling by sonodynamic therapy attenuates neointimal hyperplasia in rabbits[J]. Sci Rep202010(1):11638.
23
Zhang J Chen J Yang J,et al. Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway[J]. Cell Physiol Biochem201331(2-3):230-241.
24
Sun SC. The non-canonical NF-κB pathway in immunity and inflammation[J]. Nat Rev Immunol201717(9):545-558.
25
Williams LM Gilmore TD. Looking down on nf-κb[J]. Mol Cell Biol202040(15):104-120.
26
van Essen D Engist B Natoli G,et al. Two modes of transcriptional activation at native promoters by NF-kappaB p65[J]. PLoS Biol20097(3):e73.
27
He CY Jiang LP Wang CY,et al. Inhibition of NF-κB by pyrrolidine dithiocarbamate prevents the inflammatory response in a ligature-induced peri-implantitis model:a canine study[J]. Cell Physiol Biochem201849(2):610-625.
28
Si M Ma Z Zhang J,et al. Qingluoyin granules protect against adjuvant-induced arthritis in rats via downregulating the CXCL12/CXCR4-NF-κB signalling pathway[J]. Pharm Biol202159(1):1441-1451.
29
Zhang M Liu Y Chen J,et al. Targeting CXCL12/CXCR4 signaling with AMD3100 might selectively suppress CXCR4+ T-cell chemotaxis leading to the alleviation of chronic prostatitis[J]. J Inflamm Res202215:2551-2566.
30
Lee HH Jeong JW Hong SH,et al. Diallyl trisulfide suppresses the production of lipopolysaccharide-induced inflammatory mediators in BV2 microglia by decreasing the NF-κB pathway activity associated with toll-like receptor 4 and CXCL12/CXCR4 pathway blockade[J]. J Cancer Prev201823(3):134-140.
31
Tian X Xie GG Xiao H,et al. CXCR4 knockdown prevents inflammatory cytokine expression in macrophages by suppressing activation of MAPK and NF-κB signaling pathways[J]. Cell Biosci20199:55.

基金

国家自然科学基金资助项目(82060340)
贵州省科技计划资助项目(黔科合基础-ZK[2021]一般487)
贵州省基础研究计划项目(黔科合基础-ZK[2023]一般330)
贵州省普通高等学校青年科技人才成长项目(黔教合KY字[2021]157)

评论

PDF(2825 KB)

Accesses

Citation

Detail

段落导航
相关文章

/